Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient

Gavin R. Graff, James M. Stark, Ryan Grueber

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Dyspnea, the subjective symptom feeling of breathlessness, is a common symptom in terminally ill patients with cystic fibrosis (CF). The palliation of the dyspnea is a reasonable goal to improve patient comfort as the progression of the disease worsens. We report the successful use of inhaled fentanyl for 3 days in a 17-year-old female with terminal CF lung disease, as measured by improved oxygenation and a reduction in the modified Borg score, and the subjective feeling of less air hunger reported by parents and patient.

Original languageEnglish (US)
Pages (from-to)646-649
Number of pages4
Issue number6
StatePublished - 2004

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient'. Together they form a unique fingerprint.

Cite this